Patents by Inventor Ashley Galloway

Ashley Galloway has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190298854
    Abstract: The present invention concerns drug delivery particles which can prevent interaction between a biologically-active cargo comprised within the particles and components of an aqueous environment in which said particles are present. The particles are sensitive to pH such that above a threshold pH level the biologically-active cargo becomes accessible to the surrounding environment. Such particles are accordingly useful for stably storing a biologically-active cargo in an aqueous composition containing components which would otherwise interact deleteriously with the cargo, and releasing the cargo to mediate a biological effect in the body of an animal, such as a human, to which the composition is administered. Also provided are compositions comprising such particles, as well as methods for making and using such particles and compositions.
    Type: Application
    Filed: March 6, 2017
    Publication date: October 3, 2019
    Applicants: GLAXOSMITHKLINE BIOLOGICALS, SA, Liquidia Technologies, Inc.
    Inventors: Abdelatif A ELOUAHABI, Patrick POHLHAUS, Laurent Bernard Jean STRODIOT, Ashley GALLOWAY, Jin Christiane Lee, Michele R. STONE
  • Publication number: 20190209538
    Abstract: A composition to induce analgesia includes a plurality of particles, each particle of the plurality having 40-60 wt % amino amide anesthetic or a pharmaceutically acceptable salt, hydrate, or solvate thereof and 60-40 wt % PLGA polymer including 48:52 to 52:48 molar ratio D,L lactide:glycolide and an inherent viscosity of about 0.16 to 0.24 dL/g at 0.1% w/v in chloroform at 25° C. Each particle includes a non-spherical shape less than 100 ???? in a broadest dimension, and having a volume of about 13,500 cubic micrometers. The amino amide anesthetic is crystalline and includes 50-70% crystalline form I and 30-50% crystalline form II.
    Type: Application
    Filed: May 5, 2017
    Publication date: July 11, 2019
    Applicant: LIQUIDIA TECHNOLOGIES, INC.
    Inventors: John Robert Savage, Jacob J. Sprague, Ashley Galloway, Geoffrey Hird, Marquita Nicole Lilly, Akihisa Nonoyama, Edward Graham Randles, Benjamin Maynor
  • Publication number: 20100196277
    Abstract: Micro- and nano-particles are molded in micro- and nano-scale molds fabricated from non-wetting, low surface energy polymeric materials. The micro- and nano-particles can include pharmaceutical compositions, biologic drugs, drug compositions, organic materials, RNA, DNA, oligonucleotides, and the like.
    Type: Application
    Filed: October 9, 2007
    Publication date: August 5, 2010
    Applicant: The University of North Carolina at Chapel Hill
    Inventors: Joseph M. DeSimone, Andrew James Murphy, Ashley Galloway, Robby A. Petros